Mary Ciolkowski serves as a Senior Principal Scientist in Analytical R&D at Bausch + Lomb, where she leverages her extensive expertise in the pharmaceutical and medical device industries to drive innovation and ensure product quality. With a robust background in formulation and protein chemistry, Mary...
Mary Ciolkowski serves as a Senior Principal Scientist in Analytical R&D at Bausch + Lomb, where she leverages her extensive expertise in the pharmaceutical and medical device industries to drive innovation and ensure product quality. With a robust background in formulation and protein chemistry, Mary is a key technical leader in the development of visual inspection methodologies for ophthalmic products, particularly those packaged in opaque and semi-transparent materials. Her role involves not only the creation of these inspection approaches but also the training and qualification of inspectors in manual visual inspection practices, ensuring that high standards of quality and safety are maintained throughout the production process.
One of Mary’s notable projects includes her work as a forensic microscopist, where she specializes in the isolation, enrichment, and identification of particulate matter. This critical skill set is applied to troubleshoot complex issues related to materials, formulations, and processes in both R&D and manufacturing environments. Her expertise in powder characterization and polymorphic form assessment further enhances her contributions to product development and maintenance of business operations, particularly in the context of failure analysis and materials characterization.
Mary's proficiency in advanced analytical techniques, including IR spectroscopy and ELISA, complements her hands-on experience in clinical development and forensic analysis. Her ability to lead cross-functional teams in troubleshooting and problem-solving has made her an invaluable asset to Bausch + Lomb, where she continues to push the boundaries of innovation while ensuring compliance with stringent industry standards. Through her dedication and technical acumen, Mary is not only advancing the field of ophthalmic product development but also fostering a culture of excellence within her team.
